Abstract
The biofilm phenotype of Aspergillus species is an important and accepted clinical entity. While industrially these biofilms have been used extensively in important biofermentations, their role in clinical infection is less well defined. A recent flurry of activity has demonstrated that these interesting filamentous moulds have the capacity to form biofilms both in vitro and in vivo, and through various investigations have shown that these are exquisitely resistant to antifungal therapies through a range of adaptive resistance mechanisms independent of defined genetic changes. This review will explore the clinical importance of these biofilms and provide contemporary information with respect to their clinical management.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Amin R, Dupuis A, Aaron SD et al (2010) The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137(1):171–176
Anaissie EJ, Stratton SL, Dignani MC et al (2002) Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin Infect Dis 35:E86–E88
Bakaletz LO (2007) Bacterial biofilms in otitis media: evidence and relevance. Pediatr Infect Dis J 26:S17–S19
Bauernfeind A, Bertele RM, Harms K et al (1987) Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 15:270–277
Beauvais A, Schmidt C, Guadagnini S et al (2007) An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol 9:1588–1600
Beauvais A, Fontaine T, Aimanianda V et al (2014) Aspergillus cell wall and biofilm. Mycopathologia 178:371–377
Boase S, Valentine R, Singhal D et al (2011) A sheep model to investigate the role of fungal biofilms in sinusitis: fungal and bacterial synergy. Int Forum Allergy Rhinol 1:340–347
Bom VL, de Castro PA, Winkelstroter LK et al (2015) The Aspergillus fumigatus sitA Phosphatase Homologue Is Important for Adhesion, Cell Wall Integrity, Biofilm Formation, and Virulence. Eukaryot Cell 14:728–744
Bonhomme J, Chauvel M, Goyard S et al (2011) Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans. Mol Microbiol 80:995–1013
Branski LK, Al-Mousawi A, Rivero H et al (2009) Emerging infections in burns. Surg Infect (Larchmt) 10:389–397
Bueid A, Howard SJ, Moore CB et al (2010) Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother 65:2116–2118
Bugli F, Posteraro B, Papi M et al (2013) In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods. Antimicrob Agents Chemother 57:1275–1282
Cannon RD, Lamping E, Holmes AR et al (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22:291–321
Cetrulo CL Jr, Leto Barone AA, Jordan K et al (2012) A multi-disciplinary approach to the management of fungal osteomyelitis: current concepts in post-traumatic lower extremity reconstruction: a case report. Microsurgery 32:144–147
Chotirmall SH, O’Donoghue E, Bennett K et al (2010) Sputum Candida albicans presages FEV decline and hospital-treated exacerbations in cystic fibrosis. Chest 138:1186–1195
Cimon B, Zouhair R, Symoens F et al (2003) Aspergillus terreus in a cystic fibrosis clinic: environmental distribution and patient colonization pattern. J Hosp Infect 53:81–82
da Silva Ferreira ME, Capellaro JL, dos Reis ME et al (2004) In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother 48:4405–4413
Delhaes L, Monchy S, Frealle E et al (2012) The airway microbiota in cystic fibrosis: a complex fungal and bacterial community–implications for therapeutic management. PLoS ONE 7:e36313
Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26:781–803
Denning DW, Tucker RM, Hanson LH et al (1989) Treatment of invasive aspergillosis with itraconazole. Am J Med 86:791–800
Denning DW, Cadranel J, Beigelman-Aubry C et al (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47:45–68
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193
Dowd SE, Delton Hanson J, Rees E et al (2011) Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care 20:40–47
Ebbens FA, Georgalas C, Fokkens WJ (2009a) The mold conundrum in chronic hyperplastic sinusitis. Curr Allergy Asthma Rep 9:114–120
Ebbens FA, Georgalas C, Fokkens WJ (2009b) Fungus as the cause of chronic rhinosinusitis: the case remains unproven. Curr Opin Otolaryngol Head Neck Surg 17:43–49
Escande W, Fayad G, Modine T et al (2011) Culture of a prosthetic valve excised for streptococcal endocarditis positive for Aspergillus fumigatus 20 years after previous a fumigatus endocarditis. Ann Thorac Surg 91:e92–e93
Fan Z, Li Z, Xu Z et al (2015) cspA influences biofilm formation and drug resistance in pathogenic fungus Aspergillus fumigatus. BioMed Res Int 2015:960357
Fanning S, Mitchell AP (2012) Fungal biofilms. PLoS Pathog 8:e1002585
Fanning S, Xu W, Solis N et al (2012) Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo. Eukaryot Cell 11:896–904
Fazli M, Bjarnsholt T, Kirketerp-Moller K et al (2009) Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 47:4084–4089
Finkel JS, Mitchell AP (2011) Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 9:109–118
Foreman A, Jervis-Bardy J, Wormald PJ (2011) Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis? Laryngoscope 121:1085–1091
Fraczek MG, Bromley M, Buied A et al (2013) The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 68:1486–1496
Golmia R, Bello I, Marra A et al (2011) Aspergillus fumigatus joint infection: a review. Semin Arthritis Rheum 40:580–584
Goncalves SS, Souza AC, Chowdhary A et al (2016) Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. Mycoses. doi:10.1111/myc.12469
Gravelat FN, Doedt T, Chiang LY et al (2008) In vivo analysis of Aspergillus fumigatus developmental gene expression determined by real-time reverse transcription-PCR. Infect Immun 76:3632–3639
Gravelat FN, Ejzykowicz DE, Chiang LY et al (2010) Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence. Cell Microbiol 12:473–488
Grosjean P, Weber R (2007) Fungus balls of the paranasal sinuses: a review. Eur Arch Otorhinolaryngol 264:461–470
Gutierrez-Correa M, Ludena Y, Ramage G et al (2012) Recent advances on filamentous fungal biofilms for industrial uses. Appl Biochem Biotechnol 167:1235–1253
Harding MW, Marques LL, Howard RJ et al (2009) Can filamentous fungi form biofilms? Trends Microbiol 17:475–480
Hoiby N, Bjarnsholt T, Moser C et al (2015) ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 21:S1–S25
Howard SJ, Cerar D, Anderson MJ et al (2009) Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15:1068–1076
Jayshree RS, Shafiulla M, George J et al (2006) Microscopic, cultural and molecular evidence of disseminated invasive aspergillosis involving the lungs and the gastrointestinal tract. J Med Microbiol 55:961–964
Jeloka TK, Shrividya S, Wagholikar G et al (2011) Catheter outflow obstruction due to an aspergilloma. Perit Dial Int 31:211–212
Karkas A, Rtail R, Reyt E et al (2013) Sphenoid sinus fungus ball. Eur Arch Otorhinolaryngol 270:893–898
Keir J, Pedelty L, Swift AC et al (2011) Biofilms in chronic rhinosinusitis: systematic review and suggestions for future research. J Laryngol Otol 125:331–337
Krappmann S, Ramage G (2013) A sticky situation: extracellular DNA shapes Aspergillus fumigatus biofilms. Front Microbiol 4:159
Langer P, Kassim RA, Macari GS et al (2003) Aspergillus infection after total knee arthroplasty. Am J Orthop 32:402–404
Leclair LW, Hogan DA (2010) Mixed bacterial-fungal infections in the CF respiratory tract. Med Mycol 48:S125–S132
Leroux S, Ullmann AJ (2013) Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal. Clin Microbiol Infect 19:1115–1121
Lutz L, Pereira DC, Paiva RM et al (2012) Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm. BMC Microbiol 12:196
Maertens J, Marchetti O, Herbrecht R et al (2011) European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3–2009 update. Bone Marrow Transplant 46:709–718
Martin TJ, Kerschner JE, Flanary VA (2005) Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol 69:1503–1508
Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al (2007) A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 51:1897–1904
Meneau I, Sanglard D et al (2005) Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates. Med Mycol 43:S307–S311
Moree WJ, Phelan VV, Wu CH et al (2012) Interkingdom metabolic transformations captured by microbial imaging mass spectrometry. Proc Natl Acad Sci U S A 109:13811–13816
Morschhauser J (2010) Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47:94–106
Mosquera J, Denning DW (2002) Azole cross-resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 46:556–557
Mowat E, Butcher J, Lang S et al (2007) Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol 56:1205–1212
Mowat E, Lang S, Williams C et al (2008a) Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. J Antimicrob Chemother 62:1281–1284
Mowat E, Williams C, Jones B et al (2008b) The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm? Med Mycol 47:S120–S126
Mowat E, Rajendran R, Williams C et al (2010) Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol Lett 313:96–102
Nascimento AM, Goldman GH, Park S et al (2003) Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother 47:1719–1726
Nett JE, Sanchez H, Cain MT et al (2010) Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis 202:171–175
Nierman WC, Pain A, Anderson MJ et al (2005) Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438:1151–1156
Nobile CJ, Mitchell AP et al (2006) Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol 8:1382–1391
Odds F (1988) Candida and candidosis, 2nd edn. Bailliere Tindall, London
O’Donnell LE, Millhouse E, Sherry L et al (2015) Polymicrobial Candida biofilms: friends and foe in the oral cavity. FEMS Yeast Res 15:pii: fov077
Oren I, Rowe JM, Sprecher H et al (2006) A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. Bone Marrow Transplant 38:127–134
Peters BM, Jabra-Rizk MA, O’May GA et al (2012) Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 25:193–213
Pihet M, Carrere J, Cimon B et al (2009) Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. Med Mycol 47:387–397
Raad II, Hanna HA, Boktour M et al (2008) Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia 22:496–503
Rajendran R, Mowat E, McCulloch E et al (2011) Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrob Agents Chemother 55:2092–2097
Rajendran R, Williams C, Lappin DF et al (2013) Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Eukaryot Cell 12:420–429
Rajendran R, Mowat E, Jones B et al (2015) Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Int J Antimicrob Agents 46:342–345
Ramage G, Williams C (2013) The clinical importance of fungal biofilms. Adv Appl Microbiol 84:27–83
Ramage G, VandeWalle K, Lopez-Ribot JL et al (2002) The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214:95–100
Ramage G, Mowat E, Jones B et al (2009) Our current understanding of fungal biofilms. Crit Rev Microbiol 35:340–355
Ramage G, Rajendran R, Gutierrez-Correa M et al (2011) Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol Lett 324:89–97
Ramage G, Rajendran R, Sherry L et al (2012) Fungal biofilm resistance. Int J Microbiol 2012:528521
Richardson M (2009) The ecology of the Zygomycetes and its impact on environmental exposure. Clin Microbiol Infect 15:2–9
Robbins N, Uppuluri P, Nett J et al (2011) Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog 7:e1002257
Rosenblatt WB, Pollock A (1997) Aspergillus flavus cultured from a saline-filled implant. Plast Reconstr Surg 99:1470–1472
Rowe SM, Miller S, Sorscher EJ (2005) Mechanisms of disease: cystic fibrosis. New Engl J Med 352:1992–2001
Sambatakou H, Dupont B, Lode H et al (2006) Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med 119(527):e517–e524
Sato FR, Sawazaki R, Berretta D et al (2010) Aspergillosis of the maxillary sinus associated with a zygomatic implant. J Am Dent Assoc 141:1231–1235
Sayed SI, Datta S, Deore N et al (2012) Prevention of voice prosthesis biofilms: current scenario and future trends in prolonging prosthesis lifetime. J Indian Med Assoc 110(175–178):180
Seidler MJ, Salvenmoser S, Muller FM (2008) Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob Agents Chemother 52:4130–4136
Seth AK, Geringer MR, Hong SJ et al (2012) In vivo modeling of biofilm-infected wounds: a review. J Surg Res 178:330–338
Shopova I, Bruns S, Thywissen A et al (2013) Extrinsic extracellular DNA leads to biofilm formation and colocalizes with matrix polysaccharides in the human pathogenic fungus Aspergillus fumigatus. Front Microbiol 4:141
Short DP, O’Donnell K, Zhang N et al (2011) Widespread occurrence of diverse human pathogenic types of the fungus Fusarium detected in plumbing drains. J Clin Microbiol 49:4264–4272
Sibley CD, Duan K, Fischer C et al (2008a) Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 4:e1000184
Sibley CD, Parkins MD, Rabin HR et al (2008b) A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 105:15070–15075
Singh PK, Schaefer AL, Parsek MR et al (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762–764
Singhal D, Baker L, Wormald PJ et al (2011) Aspergillus fumigatus biofilm on primary human sinonasal epithelial culture. Am J Rhinol Allergy 25:219–225
Siqueira VM, Oliveira HM, Santos C et al (2011) Filamentous fungi in drinking water, particularly in relation to biofilm formation. Int J Environ Res Public Health 8:456–469
Smith K, Rajendran R, Kerr S et al (2015) Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures. Med Mycol 53:645–655
Snelders E, van der Lee HA, Kuijpers J et al (2008) Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5:e219
Snelders E, Karawajczyk A, Schaftenaar G et al (2010) Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother 54:2425–2430
Sudfeld CR, Dasenbrook EC, Merz WG et al (2010) Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. J Cyst Fibros Off J Eur Cyst Fibros Soc 9:110–116
Tondervik A, Sletta H, Klinkenberg G et al (2014) Alginate oligosaccharides inhibit fungal cell growth and potentiate the activity of antifungals against Candida and Aspergillus spp. PLoS ONE 9:e112518
Ullmann AJ, Cornely OA, Donnelly JP et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect 18:1–8
Uppuluri P, Chaturvedi AK, Srinivasan A et al (2010) Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog 6:e1000828
Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360
Warkentien T, Rodriguez C, Lloyd B et al (2012) Invasive mold infections following combat-related injuries. Clin Infect Dis 55:1441–1449
Williams C, Ramage G (2015) Fungal biofilms in human disease. Adv Exp Med Biol 831:11–27
Winkelstroter LK, Bom VL, de Castro PA et al (2015) High osmolarity glycerol response PtcB phosphatase is important for Aspergillus fumigatus virulence. Mol Microbiol 96:42–54
Wolcott RD, Gontcharova V, Sun Y et al (2009) Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 9:226
Yao M, Messner AH (2001) Fungal malignant otitis externa due to Scedosporium apiospermum. Ann Otol Rhinol Laryngol 110:377–380
Young RC, Bennett JE, Vogel CL et al (1970) Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 49:147–173
Zhao X, Daniels KJ, Oh SH et al (2006) Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology 152:2287–2299
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Williams, C., Rajendran, R., Ramage, G. (2016). Aspergillus Biofilms in Human Disease. In: Imbert, C. (eds) Fungal Biofilms and related infections. Advances in Experimental Medicine and Biology(), vol 931. Springer, Cham. https://doi.org/10.1007/5584_2016_4
Download citation
DOI: https://doi.org/10.1007/5584_2016_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42359-3
Online ISBN: 978-3-319-42360-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)